Aspergillomarasmine A overcomes metallo-b-lactamaseantibiotic resistance

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• β-Lactamase inhibitors: a review of the patent literature (2010 – 2013)

  2013cited by this paper
• Proliferation and significance of clinically relevant β‐lactamases

  2013cited by this paper
• Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study.

  2013cited by this paper
• “Stormy waters ahead”: global emergence of carbapenemases

  2013cited by this paper
• The Bam machine: a molecular cooper.

  2012cited by this paper
• SignalP 4.0: discriminating signal peptides from transmembrane regions

  2011cited by this paper
• Structure, function and inhibition of RND efflux pumps in Gram-negative bacteria: an update.

  2009cited by this paper
• Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae

  2008cited by this paper
• Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern

  2008cited by this paper
• A practical synthesis of nitrocefin.

  2005cited by this paper
• Journal of Antimicrobial Chemotherapy DOI: 10.1093/jac/dkg067

  2003cited by this paper
• A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

  1999cited by this paper
• Zn(II) dependence of the Aeromonas hydrophila AE036 metallo-beta-lactamase activity and stability.

  1997cited by this paper
• Pharmacological profiles of aspergillomarasmines as endothelin converting enzyme inhibitors.

  1993cited by this paper
• Aspergillomarasmine A and B, Potent Microbial Inhibitors of Endothelin-converting Enzyme

  1993cited by this paper
• Antibiotics in laboratory medicine

  1987cited by this paper
• Novel Microbial Inhibitors of Angiotensin-converting Enzyme, Aspergillomarasmines A and B

  1983cited by this paper
• A continuous spectrophotometric assay for angiotensin converting enzyme.

  1979cited by this paper
• Structure chimique des aspergillomarasmines A et B

  1965cited by this paper

• Computer-aided screening of marine fungal metabolites as potential inhibitors of new Delhi metallo-beta-lactamase-1

  2025cites this paper
• Identification of medication–microbiome interactions that affect gut infection

  2025cites this paper
• Small-molecule strategies to combat antibiotic resistance: mechanisms, modifications, and contemporary approaches

  2025cites this paper
• A Natural Depsipeptide Antibiotic that Targets the E site of the Bacterial Ribosome

  2025influential citation
• One-pot chemoenzymatic syntheses of non-canonical amino acids

  2024cites this paper
• Lasso peptides sviceucin and siamycin I have anti-virulence activity and restore vancomycin effectiveness in vancomycin-resistant Enterococcus sp. and Staphylococcus aureus

  2024cites this paper
• Kinetics, Thermodynamics, and Structural Effects of Quinoline-2-Carboxylates, Zinc-Binding Inhibitors of New Delhi Metallo-β-lactamase-1 Re-sensitizing Multidrug-Resistant Bacteria for Carbapenems.

  2023cites this paper
• Novel nitroxoline derivative combating resistant bacterial infections through outer membrane disruption and competitive NDM-1 inhibition

  2023cites this paper
• Liposomal Antibiotic Booster Potentiates Carbapenems for Combating NDMs‐Producing Escherichia c oli

  2023cites this paper
• Repurposing FDA approved drug molecules against A B C classes of β-lactamases: a computational biology and molecular dynamics simulations study

  2023cites this paper
• Prediction of Phytochemicals for Their Potential to Inhibit New Delhi Metallo β-Lactamase (NDM-1)

  2023cites this paper
• Metal-binding cyclodextrins: Synthesis and complexation with Zn2+ and Ga3+ cations towards antimicrobial applications.

  2023cites this paper
• A self-reported inhibitor of metallo-carbapenemases for reversing carbapenem resistance.

  2023cites this paper
• Structural‐Activity Relationship‐Inspired the Discovery of Saturated Fatty Acids as Novel Colistin Enhancers

  2023cites this paper
• The in vitro inhibitory activity of polypyridine ligands towards subclass B1 metallo-β-lactamases

  2023cites this paper
• A Potential Nontraditional Approach To Combat tmexCD1-toprJ1-Mediated Tigecycline Resistance: Melatonin as a Synergistic Adjuvant of Tigecycline

  2023cites this paper
• Current Insights in Fungal Importance—A Comprehensive Review

  2023cites this paper
• In-cell protein stability promotes antimicrobial resistance of metallo-β-lactamases

  2023cites this paper
• Plant secondary metabolites as an alternative to combat antimicrobial resistance: An overview of medicinal plants of Pir Panjal Himalayas

  2023cites this paper
• Neutralizing Carbapenem Resistance by Co-Administering Meropenem with Novel β-Lactam-Metallo-β-Lactamase Inhibitors

  2023cites this paper
• Auranofin Targeting the NDM-1 Beta-Lactamase: Computational Insights into the Electronic Configuration and Quasi-Tetrahedral Coordination of Gold Ions

  2023cites this paper
• Antibiotic Adjuvants: A Versatile Approach to Combat Antibiotic Resistance

  2023cites this paper
• β-Lactam potentiators to re-sensitize resistant pathogens: Discovery, development, clinical use and the way forward

  2023cites this paper
• The activity and mechanism of vidofludimus as a potent enzyme inhibitor against NDM-1-positive E. coli.

  2023cites this paper
• Metallo-β-lactamase-mediated antimicrobial resistance and progress in inhibitor discovery.

  2023cites this paper
• Distinct Inhibition Modes of New Delhi Metallo-β-lactamase-1 Revealed by NMR Spectroscopy

  2023cites this paper
• A conserved zinc-binding site in Acinetobacter baumannii PBP2 required for elongasome-directed bacterial cell shape

  2023cites this paper
• Fragment-Based Lead Discovery Strategies in Antimicrobial Drug Discovery

  2023cites this paper
• Recent Research on Hybrid Hydrogels for Infection Treatment and Bone Repair

  2022cites this paper
• Inactivation and photoreactivation of blaNDM-1-carrying super-resistant bacteria by UV, chlorination and UV/chlorination.

  2022cites this paper
• Fighting antibiotic resistance—strategies and (pre)clinical developments to find new antibacterials

  2022cites this paper
• Chemical constituents of Aspergillus udagawae isolated from the soil of the Xingren coal areas and their antibacterial activities

  2022cites this paper
• Enzymatic cascade reactions for the efficient synthesis of natural products

  2022cites this paper
• DeepBLI: A Transferable Multichannel Model for Detecting β-Lactamase-Inhibitor Interaction

  2022cites this paper
• A Unimolecular System Combining Efficient Inhibition of NDM‐1 by Coordination Interactions with High ROS for Synergistically Tackling Drug‐Resistant Bacteria

  2022cites this paper
• Drug development concerning metallo-β-lactamases in gram-negative bacteria

  2022cites this paper
• Metformin reverse minocycline to inhibit minocycline-resistant Acinetobacter baumannii by destroy the outer membrane and enhance membrane potential in vitro

  2022cites this paper
• A Cephalosporin-Tripodalamine Conjugate Inhibits Metallo-β-Lactamase with High Efficacy and Low Toxicity

  2022cites this paper
• A defect in cell wall recycling confers antibiotic resistance and sensitivity in Staphylococcus aureus

  2022cites this paper
• H 2 S Scavenger as A Universal Strategy to Deplete Bacteria-derived H 2 S for 1 Antibacterial Sensitization

  2022cites this paper
• Bioactive Metabolite Production in the Genus Pyrenophora (Pleosporaceae, Pleosporales)

  2022cites this paper
• Recent advances in β-lactamase inhibitor chemotypes and inhibition modes.

  2022cites this paper
• 1,2,4-Triazole-3-thione analogues with an arylakyl group at position 4 as metallo-β-lactamase inhibitors.

  2022cites this paper
• Three-Dimensional Structure and Optimization of the Metallo-β-Lactamase Inhibitor Aspergillomarasmine A

  2022cites this paper
• Recent Advances in the Development of Semisynthetic Glycopeptide Antibiotics: 2014–2022

  2022cites this paper
• Restoring and Enhancing the Potency of Existing Antibiotics against Drug-Resistant Gram-Negative Bacteria through the Development of Potent Small-Molecule Adjuvants.

  2022cites this paper
• Antibiotic Potentiators Against Multidrug-Resistant Bacteria: Discovery, Development, and Clinical Relevance

  2022cites this paper
• Nanomaterial-Based Zinc Ion Interference Therapy to Combat Bacterial Infections

  2022cites this paper
• A review on the mechanistic details of OXA enzymes of ESKAPE pathogens

  2022cites this paper
• Aspergilli series Versicolores: importance of species identification in the clinical setting

  2022cites this paper
• Discovery of Quercetin and Its Analogs as Potent OXA-48 Beta-Lactamase Inhibitors

  2022cites this paper
• Dihydroxyphenyl-substituted thiosemicarbazone: A potent scaffold for the development of metallo-β-lactamases inhibitors and antimicrobial.

  2022cites this paper
• Fabricating Effective Heterojunction in Metal-organic Framework-derived Self-cleanable and Dark/Visible-light Dual Mode Antimicrobial CuO/AgX (X = Cl, Br, or I) Nanocomposites

  2022cites this paper
• Discovery of environment-sensitive fluorescent probes for detecting and inhibiting metallo-β-lactamase.

  2022cites this paper
• The development of New Delhi metallo-β-lactamase-1 inhibitors since 2018.

  2022cites this paper
• Procedure of the overexpression, purification and crystallization of BLEG-1, a bifunctional and evolutionary divergent B3 metallo-β-lactamase, for structure-function studies

  2022cites this paper
• Aromatic Schiff bases confer inhibitory efficacy against New Delhi metallo-β-lactamase-1 (NDM-1).

  2022cites this paper
• Aspergillomarasmine A inhibits metallo-β-lactamases by selectively sequestering Zn2+

  2021cites this paper
• Insights on recent approaches in drug discovery strategies and untapped drug targets against drug resistance

  2021cites this paper
• Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria

  2021influential citation
• Activity of β-Lactam Antibiotics against Metallo-β-Lactamase-Producing Enterobacterales in Animal Infection Models: a Current State of Affairs

  2021cites this paper
• The ancient koji mold (Aspergillus oryzae) as a modern biotechnological tool

  2021cites this paper
• Towards the sustainable discovery and development of new antibiotics

  2021cites this paper
• Evaluation of the Organotellurium Compound AS101 for Treating Colistin- and Carbapenem-Resistant Klebsiella pneumoniae

  2021cites this paper
• In vitro and in silico screening of Klebsiella pneumoniae new Delhi metallo-β-lactamase-1 inhibitors from endophytic Streptomyces spp.

  2021influential citation
• Phenotypic and in silico studies for a series of synthetic thiosemicarbazones as New Delhi metallo-beta-lactamase carbapenemase inhibitors

  2021cites this paper
• Zinc-Chelating Compounds as Inhibitors of Human and Bacterial Zinc Metalloproteases

  2021cites this paper
• Enzyme Inhibitors: The Best Strategy to Tackle Superbug NDM-1 and Its Variants

  2021cites this paper
• Azetidinimines as a novel series of non-covalent broad-spectrum inhibitors of β -lactamases with submicromolar activities against carbapenemases of classes A, B and D

  2021cites this paper
• Polypyridine ligands as potential metallo-β-lactamase inhibitors.

  2020cites this paper
• Tackling Antibiotic Resistance with Compounds of Natural Origin: A Comprehensive Review

  2020cites this paper
• Azetidinimines as a Novel Series of Non-Covalent Broad-Spectrum Inhibitors of β-Lactamases with Submicromolar Activities Against Carbapenemases of Classes A, B and D

  2020cites this paper
• 4-Amino-1,2,4-triazole-3-thione-derived Schiff bases as metallo-β-lactamase inhibitors.

  2020cites this paper
• Inhibitors of β-Lactamases. New Life of β-Lactam Antibiotics

  2020cites this paper
• Amphiphilic cationic macromolecule potentiates tetracycline against multi-drug resistant Gram-negative bacteria

  2020cites this paper
• Cysteine Potentiates Bactericidal Antibiotics Activity Against Gram-Negative Bacterial Persisters

  2020cites this paper
• Metallo-β-Lactamases: Structure, Function, Epidemiology, Treatment Options, and the Development Pipeline

  2020cites this paper
• New Delhi metallo-β-lactamase-1 inhibitors for combating antibiotic drug resistance: recent developments

  2020cites this paper
• Metallo-β-Lactamase Inhibitors Inspired on Snapshots from the Catalytic Mechanism

  2020cites this paper
• An integrated biophysical approach to discovering mechanisms of NDM-1 inhibition for several thiol-containing drugs

  2020cites this paper
• Potential Inhibitors Against NDM-1 Type Metallo-β-Lactamases: An Overview

  2020influential citation
• Venturicidin A, A Membrane-active Natural Product Inhibitor of ATP synthase Potentiates Aminoglycoside Antibiotics

  2020cites this paper
• Antimicrobial Resistance in ESKAPE Pathogens

  2020cites this paper
• Zinc Chelators as Carbapenem Adjuvants for Metallo-β-Lactamase-Producing Bacteria: In Vitro and In Vivo Evaluation

  2020influential citation
• Small Molecule Carboxylates Inhibit Metallo-β-lactamases and Resensitize Carbapenem-Resistant Bacteria to Meropenem

  2020cites this paper
• Structure and Molecular Recognition Mechanism of IMP-13 Metallo-β-Lactamase

  2020cites this paper
• Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance

  2020cites this paper
• ZN148 Is a Modular Synthetic Metallo-β-Lactamase Inhibitor That Reverses Carbapenem Resistance in Gram-Negative Pathogens In Vivo

  2020cites this paper
• Recent advances in the chemoenzymatic synthesis of bioactive natural products.

  2020cites this paper
• Suppression of β-Lactam Resistance by Aspergillomarasmine A Is Influenced by both the Metallo-β-Lactamase Target and the Antibiotic Partner

  2020cites this paper
• Heteroaryl phosphonates as non-covalent inhibitors of both serine and metallo-carbapenemases.

  2019cites this paper
• Inhibitors of Selected Bacterial Metalloenzymes.

  2019cites this paper
• Discovery of [1,2,4]Triazole Derivatives as New Metallo-β-Lactamase Inhibitors

  2019cites this paper
• Dithiocarbamate as a Valuable Scaffold for the Inhibition of Metallo-β-Lactmases

  2019cites this paper
• β-Lactamases a Inhibitors in the

  2019cites this paper
• The antimicrobial peptide thanatin disrupts the bacterial outer membrane and inactivates the NDM-1 metallo-β-lactamase

  2019cites this paper
• Next-generation strategy for treating drug resistant bacteria: Antibiotic hybrids

  2019cites this paper
• Discovery of Baicalin as NDM-1 inhibitor: Virtual screening, biological evaluation and molecular simulation.

  2019cites this paper
• Antibiotic Adjuvants: Make Antibiotics Great Again!

  2019cites this paper
• β-Lactamases and β-Lactamase Inhibitors in the 21st Century. Journal of Molecular Biology.

  2019cites this paper